Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Change in Accured Expenses: 2021-2025

Historic Change in Accured Expenses for biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $2.4 million.

  • biote's Change in Accured Expenses rose 6513.2% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.1 million, marking a year-over-year decrease of 25840.55%. This contributed to the annual value of $4.6 million for FY2024, which is 10836.71% up from last year.
  • Per biote's latest filing, its Change in Accured Expenses stood at $2.4 million for Q3 2025, which was up 6513.2% from -$1.2 million recorded in Q2 2025.
  • biote's Change in Accured Expenses' 5-year high stood at $4.9 million during Q3 2023, with a 5-year trough of -$26.1 million in Q2 2022.
  • In the last 5 years, biote's Change in Accured Expenses had a median value of -$135000.0 in 2021 and averaged -$1.1 million.
  • Per our database at Business Quant, biote's Change in Accured Expenses crashed by 3298668.13% in 2022 and then surged by 35858.59% in 2024.
  • Over the past 5 years, biote's Change in Accured Expenses (Quarter) stood at $2.7 million in 2021, then plummeted by 79.64% to $555000.0 in 2022, then tumbled by 421.08% to -$1.8 million in 2023, then soared by 358.59% to $4.6 million in 2024, then crashed by 47.07% to $2.4 million in 2025.
  • Its Change in Accured Expenses stands at $2.4 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$2.7 million for Q1 2025.